VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by Veritas33on Mar 09, 2017 10:00am

90 Views

Post# 25956524

RE:RE:RE:RE:RE:RE:RE:RE:MSVanton

For the uninformed, the TSX approves all PP pricing. Company can price a PP at no less that 25% below the closing price for that trading day. Those are the TSX rules. On Tuesday the closing share price for VPT was 42c. I'm sure you call all do the math!

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale